Given the relatively higher HR (hazard ratio) and clearer separation between high-risk and low-risk groups in the survival curves (Supplementary Table S3), we suggest that the prognostic model was more effective than CREB1 expression or tumor stage alone to predict patients' outcome. This evidence concerns the gene CREB1 and neoplasm.